论文部分内容阅读
乙型肝炎(下称乙肝)是一种严重危害人类健康的世界性分布的急性传染病,主要侵犯儿童和青壮年,感染后约5～10%可发展成肝硬化,且与原发性肝癌有密切关系。我国为乙肝高发区,约有一亿人为 HBsAg 携带者。目前对乙肝尚无特效疗法,而乙肝疫苗的问世为预防乙肝提供了有效手段。我们于1986年5月开始采用国产血源性乙肝疫苗对健康儿童免疫效
Hepatitis B (hereinafter referred to as hepatitis B) is a worldwide acute infectious disease that seriously affects human health. It mainly affects children and young adults. Approximately 5 to 10% of the patients can develop cirrhosis after infection, and is associated with primary liver cancer There is a close relationship. China is a high incidence of hepatitis B, about 100 million people are HBsAg carriers. At present there is no specific treatment for hepatitis B, and the advent of hepatitis B vaccine for the prevention of hepatitis B provides an effective means. In May 1986, we started to use domestic blood-borne hepatitis B vaccine to immunize healthy children